M Carrier, J Tay, D Fergusson, P S Wells. Show Affiliations »
Abstract
Entities: Disease Species
Mesh： See more » Anticoagulants/adverse effectsAnticoagulants/therapeutic useAntineoplastic Agents/administration & dosageCatheterization/adverse effectsCatheterization/instrumentationCatheters, Indwelling/adverse effectsHemorrhage/chemically inducedHeparin, Low-Molecular-Weight/therapeutic useHumansNeoplasms/drug therapyPractice Guidelines as TopicRandomized Controlled Trials as TopicVenous Thrombosis/etiologyVenous Thrombosis/prevention & controlWarfarin/therapeutic use
Substances： See more » AnticoagulantsAntineoplastic AgentsHeparin, Low-Molecular-WeightWarfarin
Year: 2007 PMID： 18034768 DOI： 10.1111/j.1538-7836.2007.02751.x
Source DB: PubMed Journal: J Thromb Haemost ISSN： 1538-7836 Impact factor: 5.824